Time‐based measures for quantifying disease modification in Alzheimer’s disease

Lars Lau Raket · 2025

Read Time‐based measures for quantifying disease modification in Alzheimer’s disease by Lars Lau Raket (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713721.txt.

Description

Lars Lau Raket argues this 2025 case for measuring Alzheimer's treatment effects in units of time. New drugs aim to slow the disease itself, not just ease symptoms. Standard trial statistics report a score gap at one visit. That gap wastes data across visits, says little about real benefit, and resists comparison between trials.

Raket compares the standard approach with two time-based ones that model disease progression directly. Using data from a large trial of the drug donanemab, the time-based measures used information across visits better and detected effects with more power. They also express benefit as time saved, a unit patients and doctors grasp at once. The paper urges trial designers to weigh assumptions against these gains when choosing measures.

Catalog record

CREATORLars Lau Raket
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11713721

Browse the full library · About the Tower of Babel